Evidence map›Paper›PMID 30838918›Full record

ArticleEpilepsy currents2019

A Matter of Genes: The Hurdles of Gene Therapy for Epilepsy.

Selene Ingusci, Stefano Cattaneo, Gianluca Verlengia, Silvia Zucchini, Michele Simonato

Open access · diamondAbstract read
In one paragraph

Article in Epilepsy currents, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Epileptic seizures.Discoveries (Craiova, Romania) · 2020
    Review
  9. NPY and Gene Therapy for Epilepsy: How, When,... and Y.Frontiers in molecular neuroscience · 2020
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Selene Ingusci1 Department of Medical Sciences and National Institute of Neuroscience, University of Ferrara, Ferrara, Italy.
Stefano Cattaneo2 School of Medicine, University Vita-Salute San Raffaele, Milan, Italy.
Gianluca Verlengia1 Department of Medical Sciences and National Institute of Neuroscience, University of Ferrara, Ferrara, Italy.
Silvia Zucchini1 Department of Medical Sciences and National Institute of Neuroscience, University of Ferrara, Ferrara, Italy.
Michele Simonato1 Department of Medical Sciences and National Institute of Neuroscience, University of Ferrara, Ferrara, Italy.
Vita-Salute San Raffaele University · ITUniversity of Ferrara · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gene therapy has recently advanced to the level of standard of care for several diseases. However, its application to neurological disorders is still in the experimental phase. In this review, we discuss recent advancements in the field that provide optimism on the possibility to have first-in-human studies for gene therapy of some forms of epilepsy in the not so distant future.

Indexed as

Gene therapyViral vectors

Identifiers

PMID30838918
PMCPMC6610370
OpenAlexW2914823219

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.